Hilton Hotels Corporation Common Stock vs Tilray Brands Inc — how do they compare? Hilton Hotels Corporation Common Stock trades at $323.65 (market cap $73.63B), while Tilray Brands Inc trades at $4.27 (market cap $524.07M). The key difference: Hilton Hotels Corporation Common Stock is far larger — about 140.5× Tilray Brands Inc's market cap, and Hilton Hotels Corporation Common Stock pays a 0.19% dividend while Tilray Brands Inc pays none. Which is the better fit depends on your goals.
| HLT | TLRY | |
|---|---|---|
Market Cap | $73.63B | $524.07M |
Sector | Consumer Cyclical | Health |
52-Week High | $350.22 | $21.00 |
52-Week Low | $256.75 | $4.23 |
Enterprise Value | $86.12B | $621.22M |
Dividend Yield | 0.19% | — |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
TLRY trades at $4.23, down 1.63% with bearish technical signals. The company reported revenue growth to $821.31M in 2025 but faces severe profitability challenges with a net loss of $2.19B and negative margins. Recent expansion includes medical cannabis launches in Panama and strategic acquisitions, while analyst consensus shows cautious sentiment with 65% hold ratings.
The outlook remains challenging due to persistent losses and high debt levels, though expansion initiatives and potential regulatory changes offer long-term opportunities. Key risks include execution on profitability, competitive pressures, and cannabis regulatory uncertainty.
Trailing returns across standard periods
Latest headlines on both assets
Hilton Worldwide Holdings operates 1,074,791 rooms across its 18 brands addressing the midscale through luxury segments as of Dec. 31, 2021. Hampton and Hilton are the two largest brands by total room count at 28% and 21%, respectively, as of Dec. 31, 2021. Recent brands launched over the last few years include Home2, Curio, Canopy, Tru, and Tempo. Managed and franchised represent the vast majority of adjusted EBITDA, predominantly from the Americas regions.
Read more on HLT →Tilray is a Canadian company that grows and sells medical and recreational cannabis. In 2021, Aphria acquired Tilray in a reverse merger and adopted the Tilray name. Most of its sales come from Canada and international medical cannabis exports, while its U.S. business focuses on CBD products and alcohol.
Read more on TLRY →